SEARCH

SEARCH BY CITATION

References

  • 1
    Bailly, J.D., Muller, C., Jaffrézou, J.P., Demur, C., Gassar, G., Bordier, C., Laurent, G. (1995) Lack of correlation between expression and function of Pgp in acute myeloid leukemia cells. Leukemia, 9, 799 807.
  • 2
    Ball, E.D., Davis, R.B., Griffin, J.D., Mayer, R.J., Davey, F.R., Arthur, D.C., Wurster-Hill, D., Noll, W., Tarek, M., Allen, S.L., Rai, K., Lee, E.J., Schiffer, C.A., Bloomfield, C.D. (1991) Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood, 77, 2242 2250.
  • 3
    Beck, W.T., Grogan, T.M., Willman, C.L., Cordon-Cardo, C., Parham, D.M., Kuttesch, J.F., Andreeff, M., Bates, S.E., Berard, C.W., Boycott, J.M., Brophy, N.A., Broxterman, H.J., Chan, H.S.L., Dalton, W.S., Dielt, M., Fojo, A.T., Gascoyne, R.D., Head, D., Houghton, P.J., Kumar Svrivastava, D., Lehnert, M., Leith, C.P., Paietta, E., Pavelic, Z.P., Rimsza, L., Roninson, I.B., Sikic, B.I., Twentyman, P.R., Warnke, R., Weinstein, R. (1996) Methods to detect P-glycoprotein-associated multidrug resistance in patient tumors: consensus recommendations. Cancer Research, 56, 3010 3020.
  • 4
    Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, N.R., Sultan, C. (1981) The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. British Journal of Haematology, 47, 553 561.
  • 5
    Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, N.R., Sultan, C. (1985) Proposed revised criteria for the classification of acute myeloid leukemia. Annals of Internal Medicine, 103, 620 625.
  • 6
    Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, N.R., Sultan, C. (1991) Proposal for the recognition of minimally differentiated acute myeloid leukaemia. British Journal of Haematology, 78, 325 329.
  • 7
    Berger, R., Bernheim, A., Ochoa-Noguera, M.E., Daniel, M.T., Valensi, F., Sigaux, F., Flandrin, G., Boiron, M. (1987) Prognostic significance of chromosomal abnormalities in acute nonlymphocytic leukemia: a study of 343 patients. Cancer Genetics and Cytogenetics, 28, 293 299.
  • 8
    Boldt, D., Kopecky, K.J., Head, D., Gehly, G., Radich, J.P., Appelbaum, F.R. (1994) Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults: the Southwest Oncology Group Experience. Leukemia, 8, 2118 2126.
  • 9
    Buccheri, V., Matutes, E., Dyer, M.J.S., Catovsky, D. (1993) Lineage commitment in biphenotypic acute leukemia. Leukemia, 7, 919 927.
  • 10
    Büchner, T. & Heinecke, A. (1996) The role of prognostic factors in acute myeloid leukemia. Leukemia, 10, (Suppl. 1), S28 S29.
  • 11
    Carbonell, F., Swansbury, J., Min, T., Matutes, E., Farahat, N., Buccheri, V., Morilla, R., Secker-Walker, L., Catovsky, D. (1996) Cytogenetic findings in acute biphenotypic leukemia. Leukemia, 10, 1283 1287.
  • 12
    Catovsky, D., Matutes, E., Buccheri, V., Shetty, V., Hanslip, J., Yoshida, N., Morilla, R. (1991) A classification of acute leukemia for the 1990s. Annals of Hematology, 62, 16 21.
  • 13
    Cuneo, A., Michaux, J.L., Ferrant, A., Van Hove, L., Bosly, A., Stul, M., Dal Cin, P., Vandenberghe, E., Cassiman, J.J., Negrini, M., Piva, N., Castoldi, G., Van Den Berghe, H. (1992) Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukemia expressing lymphoid markers. Blood, 79, 720 727.
  • 14
    Curtis, A.H., Abaza, M., Sheldon, S., Ross, C.W., Schnitzer, B., Stoolman, L.M. (1993) Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis. British Journal of Haematology, 85, 49 60.
  • 15
    Dinndorf, P.A., Andrews, R.G., Benjamin, D., Ridgway, D., Wolff, L. (1986) Expression of normal myeloid associated antigens by acute leukemia cells. Blood, 67, 1048 1053.
  • 16
    Filipits, M., Suchomel, R.W., Zöchbauer S., Brunner, R., Lechner, K., Pirker, R. (1997) Multidrug resistance-associated protein in acute myeloid leukemia: no impact on treatment outcome. Clinical Cancer Research, 3, 1419 1425.
  • 17
    Fourth International Workshop on Chromosomes in Leukemia (1984) Clinical significance of chromosomal abnormalities in acute nonlymphoblastic leukemia. Cancer Genetics and Cytogenetics, 11, 332 350.
  • 18
    Gale, R.P. & Bassat, I.B. (1987) Hybrid leukaemia. British Journal of Haematology, 65, 261 264.
  • 19
    Hanson, C.A., Abaza, M., Sheldon, S., Ross, C.W., Schnitzer, B., Stoolman, L.M. (1993) Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis. British Journal of Haematology, 84, 49 60.
  • 20
    Hayashi, Y., Sugita, K., Nakasawa, S., Abe, T., Kojima, S., Inaba, T., Hanada, R., Yamamoto, K. (1990) Karyotypic patterns in acute mixed lineage leukemia. Leukemia, 4, 121 126.
  • 21
    Hoelzer, D., Thiel, E., Loffler, H., Buchner, T., Ganser, A., Heil, G., Koch, P., Freund, M., Diedrich, H., Ruhl, H., Maschmeyer, G., Lipp, T., Nowroussian, M.R., Burkert, M., Gerecke, D., Pralle, H., Muller, U., Lunscken, C., Fulle, H., Ho, A.D., Kuchler, R., Bush, F.W., Schneider, W., Gorg, C., Emmerich, B., Braumann, D., Vaupel, H.A., Von Paleske, A., Bartels, H., Neiss, A., Messerer, A. (1988) Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood, 71, 123 133.
  • 22
    Hunault, M., Zhou, D.C., Delmer, A., Ramond, S., Viguié, F., Cadiou, M., Perrot, J.Y., Levy, V., Rio, B., Cymbalista, F., Zittoun, R., Marie, J.-P. (1997) Multidrug resistance (MDR1) gene expression in acute myeloid leukemia: major prognosis significance for the in vivo drug resistance to induction treatment. Annals of Hematology, 74, 65 69.
  • 23
    ISCN (1995) An International System for Human Cytogenetic Nomenclature (ed. by F. Mitelman). Karger, Basel.
  • 24
    Kantarjian, H.M., Hirsch-Ginsberg, C., Yee, G., Huh, Y., Freireich, E.J., Stass, S. (1990) Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxydase-positive blasts by electron microscopy. Blood, 76, 808 813.
  • 25
    Kaplan, E.I. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457 481.
  • 26
    Kita, K., Nakase, K., Miwa, H., Masuya, M., Nishii, K., Morita, N., Takakura, N., Otsuji, A., Shirakawa, S., Ueda, T., Nasu, K., Kyo, T., Dohy, K., Kamada, N. (1992) Phenotypical characteristics of acute myelocytic leukemia associated with t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood, 80, 470 477.
  • 27
    Legrand, O., Perrot, J.-Y., Tang, R.P., Simonin, G., Gurbuxani, S., Zittoun, R., Marie, J.-P. (1996) Expression of the multidrug resistance-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells. British Journal of Haematology, 94, 23 33.
  • 28
    List, A.F., Spier, C.S., Grogan, T.M., Johson, C., Roe, D.J., Greer, J.P., Wolff, S.N., Broxterman, H.J., Scheffer, G.L., Scheper, R.J., Dalton, W.S. (1996) Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood, 87, 2464 2469.
  • 29
    Lo Coco, F., De Rossi, G., Pasqualette, D., Lopez, M., Diverio, D., Latagliata, R., Fenu, S., Mandelli, F. (1989) CD7 positive acute myeloid leukaemia: a subtype associated with cell immaturity. British Journal of Haematology, 73, 480 485.
  • 30
    Marie, J.-P., Simonin, G., Legrand, O., Delmer, A., Faussat, A.-M., Lewis, A.D., Sikic, B.I., Zittoun, R. (1995) Glutathione-S-transferases π, μ and mdr1 mRNA expression in normal lymphocytes and chronic lymphocytic leukemia. Leukemia, 9, 1742 1747.
  • 31
    Marie, J.-P., Zhou, D.C., Gurbuxani, S., Legrand, O., Zittoun, R. (1996) MDR1/P-glycoprotein in haematological neoplasms. European Journal of Cancer, 32A, 1034 1038.
  • 32
    Noonan, K.E. & Roninson, I.B. (1991) Quantitative estimation of MDR1 mRNA levels by polymerase chain reaction. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells (ed. by I. B. Robinson), pp. 319 333. Plenum Press, New York.
  • 33
    Pui, C.H., Behm, F.G., Singh, B., Rivera, G.K., Schell, M.J., Roberts, W.M., Crist, W.M., Miro, J. (1989) Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood, 75, 198 202.
  • 34
    Reading, C.L., Estey, E.H., Huh, Y.O., Claxton, D.F., Sanchez, G., Terstappen, L.W.M.M., O'brien, M.C., Baron, S., Deisseroth, A.B. (1993) Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood, 81, 3083 3090.
  • 35
    Saikevych, I.A., Kerrigan, D.P., McConnell, T.S., Head, D.R., Appelbaum, F.R., Willmam, C.L. (1991) Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology. Leukemia, 5, 373 382.
  • 36
    Scheffer, G.L., Winjngaard, L.J., Flens, M.J., Izquierdo, M.A., Slovak, M.L., Pinedo, H.M., Meijer, C.J.L.M., Clevers, H.C., Scheper, R.J. (1995) The drug resistance-related protein LRP is the human major vault protein. Nature Medicine, 1, 578 582.
  • 37
    Secker-Walker, L.M., Prentice, H.G., Durrant, J., Richards, S., Hall, E., Harrison, G. (1997) Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. British Journal of Haematology, 96, 601 610.
  • 38
    Sobol, R.E., Mick, R., Royston, I., Davey, F.R., Ellison, R.R., Newman, R., Cuttner, J., Griffin, J.D., Collins, H., Nelson, D.A., Bloomfield, C.D. (1987) Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. New England Journal of Medicine, 316, 1111 1117.
  • 39
    Stryckmans, P., De Witte, T., Marie, J.-P., Fillet, G., Peeterman, M., Bury, J., Muus, P., Andrien, J.M., Hayat, M., Jaksic, B., Labar, B., Debusscher, L., Solbu, G., Suciu, S., Zittoun, R. (1992) Therapy of adult ALL: overview of two successive EORTC studies (ALL2 and ALL3). Leukemia, 6, (Suppl. 2), 199 203.
  • 40
    Te Boekhorst, P.A.W., De Leeuw, K., Schoester, M., Wittebol, S., Nooter, K., Hagemeijer, A., Löwenberg, B., Sonneveld, P. (1993) Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. Blood, 82, 3157 3162.
  • 41
    Urbano-Ispizua, A., Matutes, E., Villamor, N., Ribera, J.M., Feliu, E., Montserrat, E., Granena, A., Vives-Corrons, J.L., Rozan, C. (1990) Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia. British Journal of Haematology, 75, 202 207.
  • 42
    Young, I.T. (1977) Proof without prejudice: use of the Komogorov-Smirnov test for the analysis of histograms from flow systems and other sources. Journal of Histochemistry and Cytochemistry, 25, 935 941.
  • 43
    Yunis, J.J., Brunning, R.D., Howe, R.B., Lobell, M. (1984) High-resolution chromosomes as an independent prognostic indicator in adult acute nonlymphocytic leukemia. New England Journal of Medicine, 311, 812 818.
  • 44
    Zhou, D.C., Zittoun, R., Marie, J.-P. (1995) Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia. Leukemia, 9, 1661 1666.